Introduction
Leading pharma company reported a net profit of ₹66.18 crore in Q1 FY26, marking a 294% year-on-year growth and an 8% rise compared to the previous quarter’s ₹61.18 crore.
Also Read: Green energy stock under ₹70 jumps 8% after receiving order from Zelestra
Share price movement of P&G
On August 1, 2025, Procter & Gamble Health Ltd opened at ₹5,935.50, up 0.61% from its previous close of ₹5,899.55. The stock hit a high of ₹6,490.00 and a low of ₹5,901.00. By 4:01 PM, it traded at ₹6,199.70, rising 5.09%, with a market cap of ₹10,291.12 crore.
Procter & Gamble Health Q1 Profit Surges 294%
Procter & Gamble Health Ltd reported a net profit of ₹66.18 crore in Q1 FY26, up 294% year-on-year from ₹16.78 crore in Q1 FY25. On a sequential basis, profit rose 8% from ₹61.18 crore.
The company’s revenue from operations stood at ₹338.74 crore in Q1 FY26, reflecting a 19.3% year-on-year increase from ₹283.88 crore and a 9% rise quarter-on-quarter from ₹310.99 crore reported in Q4 FY25.
Total income for Q1 FY26 reached ₹342.77 crore, up 19.8% from ₹286.01 crore in Q1 FY25. Compared to Q4 FY25, total income increased by 9.1%, rising from ₹314.10 crore.
Stock performance of P&G for Period of 1 week, 6 months, and 1 year
Procter & Gamble Health Ltd delivered a 7.00% return over the past week. It gained 15.3% in the past six months and recorded a 17.2% return over the past year.
Also Read: Auto stock hits 5% upper circuit after its sales rise up by 18.6% YoY
Shareholding pattern of P&G
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
| Promoter | 51.80% | 51.80% | 51.80% |
| FII | 7.00% | 6.90% | 7.00% |
| DII | 14.20% | 14.20% | 14.70% |
| Public | 27.00% | 27.10% | 26.50% |
About P&G
Procter & Gamble Health Ltd (NSE: PGHL) is a leading pharmaceutical company in India, manufacturing and marketing vitamins, minerals, supplements, and key pharma brands like Evion, Neurobion, and Nasivion.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.


